Assessment of the potential interactions between favipiravir and radiocontrast agents

doi:10.4329/wjr.v16.i5.128

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (972)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

400

Figures (1-1)

Tables (1-5)

Sum=579

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

163

Sum=243

Publishing Process of This Article

Item

Count

Browse

Download

Sum=112

May 28, 2024 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Radiol. May 28, 2024; 16(5): 128-135
Published online May 28, 2024. doi: 10.4329/wjr.v16.i5.128

Table 3 Use of magnetic resonance imaging contrast agents, n (%)

MRI contrast agent	Number of patients
Meglumine gadoterate	158 (56.2)
Gadoxetic acid disodium	123 (43.8)
Total	281 (100)

MRI: Magnetic resonance imaging.

Citation: Aydin S, Aydin OC, Yazar MF, Aydemir H, Kantarci M, Barun S. Assessment of the potential interactions between favipiravir and radiocontrast agents. World J Radiol 2024; 16(5): 128-135
URL: https://www.wjgnet.com/1949-8470/full/v16/i5/128.htm
DOI: https://dx.doi.org/10.4329/wjr.v16.i5.128